Remove news weight-loss
article thumbnail

Your Body Has a Built-in Weight Loss System You May Not Know About

AuroBlog - Aurous Healthcare Clinical Trials blog

Wegovy, Ozempic and Mounjaro are weight loss and diabetes drugs that have made quite a splash in health news. They target regulatory pathways involved in both obesity and diabetes and are widely considered breakthroughs for weight loss and blood sugar control. What […]

Drugs 193
article thumbnail

Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News

BioSpace

weight loss, and nearly a third of those taking the highest dose lost at least 20% of their body weight. Patients treated with Altimmune’s investigational GLP-1/glucagon dual receptor agonist saw up to 15.6%

106
106
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Unique Weight Loss Method – Blue Heron Health News

The Pharma Data

Product Name: New Unique Weight Loss Method – Blue Heron Health News. New Unique Weight Loss Method – Blue Heron Health News is backed with a 60 Day No Questions Asked Money Back Guarantee.

article thumbnail

Lilly has a new blockbuster

World of DTC Marketing

The drug led to impressive blood sugar and body weight drops in clinical trials. The approval for tirzepatide—which Lilly will market under the brand name Mounjaro—isn’t for weight loss but Type 2 diabetes. When it comes to losing weight, Americans want shortcuts, and if it’s a prescription drug, it doesn’t matter.

Drugs 218
article thumbnail

STAT+: Doctors’ group complains that 60 Minutes segment on Wegovy was really just an ad

STAT News

A physicians’ group has filed a complaint with the Food and Drug Administration alleging that a recent 60 Minutes segment about the Wegovy weight-loss drug was actually an advertisement and demanded the agency withdraw the report from circulation. At issue was a Jan. At issue was a Jan.

Doctors 98
article thumbnail

STAT+: Pharmalittle: Lilly diabetes drug back on shelves after two-month shortage; AbbVie sued for human rights violations over Humira pricing

STAT News

… Eli Lilly says that all doses of its new Mounjaro diabetes drug are now available after social-media enthusiasm about weight-loss benefits sparked a two-month-long shortage , Bloomberg News tells us. The drug was approved in the U.S. last May to help people with type 2 diabetes control their blood sugar levels.

Drugs 98
article thumbnail

Wegovy: What you need to know about this weight loss drug

Medical Xpress

A much-hyped weight-loss jab will soon go on sale at high street chemists in the UK. Although a prescription will still be needed from a doctor to buy the drug, the news will no doubt be welcome to the many millions of people who have struggled to lose weight.

Drugs 69